Hematological Side Effects of <sup>177</sup>Lu-DOTA-TATE Therapy in Patients with NENs

<b>Background/Objectives</b>: Lutathera<sup>®</sup> ([<sup>177</sup>Lu]Lu-DOTA-TATE) is the first radiolabelled somatostatin (SST) analog approved for the treatment of patients with well-differentiated (G1 and G2) unresectable or metastatic gastro-entero-pancreati...

Full description

Bibliographic Details
Published in:Hemato
Main Authors: Luciano Carideo, Rosaria Meucci, Giuseppe Campagna, Vincenzo Marcello Russo, Enrico D’Ippolito, Maria Rinzivillo, Francesco Panzuto, Daniela Prosperi
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Subjects:
hematological toxicity
neuroendocrine tumors
nuclear medicine therapy
<sup>177</sup>Lu-DOTA-TATE
bone marrow irradiation
Online Access:https://www.mdpi.com/2673-6357/6/1/1

Internet

https://www.mdpi.com/2673-6357/6/1/1

Similar Items